BANDUNG - World demand for vaccine demand continues to increase. The average world vaccine demand is up by 15 percent annually. Increased needs of this vaccine must be balanced with the supply. The problem is that only a few countries in the world are able to produce vaccines and meet WHO qualifications.
One of them is PT Bio Farma, the only state-owned company producing vaccines in Indonesia even in Asia. The absence of vaccine-making technology becomes an obstacle to the development of vaccines, in keeping with the needs of the world.
Although already independent even able to supply the world's vaccine needs, Bio Farma aware if it turns out the vaccine needs bigger and can not be handled alone. Especially for developing countries in the world, the need for vaccines is still very dependent on Bio Farma.
For that reason Bio Farma continues to initiate cooperation with developing countries in the world and establish the Developing Countries Vaccine Manufacture Network (DCVMN). Not only supplying vaccines to member countries but also transferring technology.
Director of Bio Farma M Rahman Rustan said the need for vaccines is needed as the population continues to increase in the world and also continue the emergence of new types of diseases. Bio Farma as one of the world's vaccine producers has a responsibility to overcome the problem.
"We supply not only in the form of vaccine so also raw materials or bulk," he said not long ago.
Bulk exports are intended to make other countries also capable of making vaccines without having to do research and research very long. In addition to supply vaccine cooperation, Bio Farma also want to explore the potential of research cooperation or production cooperation that can be synergized with friendly countries.
"We send experts to the country, teach how to make vaccines from raw materials that already exist," he said.
Until now Bio Farma Vaccine has spread over 130 countries in the world. Even Bio Farma has been able to supply 70 percent of the world's vaccine needs. Supply is done both through the UN in this case UNICEF, but also through bilateral relations.
Now, according to him, it is necessary close cooperation between developing countries so that vaccine supply can be done directly without through UNICEF path, so it can cut time and cost.
"If we work together before through UNICEF, we hope there will be easier access to bilateral cooperation because of the assistance from the Ambassadors of Indonesia," Rahman sata met with several ambassadors in Bandung recently.
The Ambassador of the Republic of Indonesia, including Octavino Alimudin, Ambassador of the Republic of Indonesia to Iran and Turkmenistan representing the Middle East Region, said that they can receive information directly about Bio Farma's efforts in assisting the distribution of vaccines for national and international needs.
He considered the position of Indonesia as a producer of vaccine and serum is highly recognized by the world, even a new market potential for Indonesia through Bio Farma.
"This can really help us to be able to re-establish and pioneer everything that would be beneficial for both parties," said Octavino
He added that in the future there will be formal cooperation, either in the form of MoU or other contracts, or something to be obtained from each region Country. In addition, the ambassador will seek what potential can be explored from the country.
Based on the import export in accordance with the direction of the President of the Republic of Indonesia, Indonesia does not only accept but it is time to provide assistance.
"All things that are political must of course we describe in the form of mutually beneficial economic cooperation" concluded Octaino.